The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
89BIO INC | COM | 282559103 | 1,272,250 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
ABIVAX SA | SPONSORED ADS | 00370M103 | 1,250,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
ADAGIO MED HLDGS INC | COM | 00534B100 | 169,543 | 213,235 | SH | SOLE | 213,235 | 0 | 0 | ||
AEROVATE THERAPEUTICS INC | COM | 008064107 | 2,008,000 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
AKEBIA THERAPEUTICS INC | COM | 00972D105 | 2,880,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
ALKERMES PLC | SHS | G01767105 | 33,020,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
ALLAKOS INC | COM | 01671P100 | 56,900 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 14,851,100 | 55,000 | SH | Call | SOLE | 55,000 | 0 | 0 | |
AMGEN INC | COM | 031162100 | 21,808,500 | 70,000 | SH | Call | SOLE | 70,000 | 0 | 0 | |
ANTERIS TECHNOLOGIES GLOBAL | COM | 03675P102 | 1,419,600 | 390,000 | SH | SOLE | 390,000 | 0 | 0 | ||
APOGEE THERAPEUTICS INC | COM | 03770N101 | 43,008,795 | 1,151,199 | SH | SOLE | 1,151,199 | 0 | 0 | ||
ARCELLX INC | COMMON STOCK | 03940C100 | 34,768,000 | 530,000 | SH | SOLE | 530,000 | 0 | 0 | ||
AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | 4,719,750 | 3,045,000 | SH | SOLE | 3,045,000 | 0 | 0 | ||
AVALO THERAPEUTICS INC | COM NEW | 05338F306 | 5,263,804 | 657,154 | SH | SOLE | 657,154 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 11,663,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
BLACK DIAMOND THERAPEUTICS I | COM | 09203E105 | 387,500 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 10,371,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 22,241,000 | 1,546,662 | SH | SOLE | 1,546,662 | 0 | 0 | ||
CLIMB BIO INC | COM | 28658R106 | 1,830,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
COMPASS THERAPEUTICS INC | COM | 20454B104 | 248,533 | 130,807 | SH | SOLE | 130,807 | 0 | 0 | ||
COMPASS THERAPEUTICS INC | COM | 20454B104 | 2,528,330 | 1,330,700 | SH | Put | SOLE | 1,330,700 | 0 | 0 | |
CONTEXT THERAPEUTICS INC | COM | 21077P108 | 404,280 | 660,589 | SH | SOLE | 660,589 | 0 | 0 | ||
CORCEPT THERAPEUTICS INC | COM | 218352102 | 7,995,400 | 70,000 | SH | Call | SOLE | 70,000 | 0 | 0 | |
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 5,106,532 | 152,252 | SH | SOLE | 152,252 | 0 | 0 | ||
CULLINAN THERAPEUTICS INC | COM | 230031106 | 1,997,095 | 263,817 | SH | SOLE | 263,817 | 0 | 0 | ||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 4,400,000 | 200,000 | SH | Put | SOLE | 200,000 | 0 | 0 | |
ERASCA INC | COM | 29479A108 | 4,577,881 | 3,341,519 | SH | SOLE | 3,341,519 | 0 | 0 | ||
ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | 11,425,400 | 280,000 | SH | SOLE | 280,000 | 0 | 0 | ||
EXELIXIS INC | COM | 30161Q104 | 4,984,200 | 135,000 | SH | Call | SOLE | 135,000 | 0 | 0 | |
GALECTIN THERAPEUTICS INC | COM NEW | 363225202 | 2,240,164 | 1,836,200 | SH | Put | SOLE | 1,836,200 | 0 | 0 | |
GERON CORP | COM | 374163103 | 2,385,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
IMMATICS N.V | *W EXP 07/01/202 | N44445117 | 2,958 | 187,204 | SH | SOLE | 187,204 | 0 | 0 | ||
IMMUNITYBIO INC | COM | 45256X103 | 3,085,250 | 1,025,000 | SH | Put | SOLE | 1,025,000 | 0 | 0 | |
IMMUNOVANT INC | COM | 45258J102 | 7,348,700 | 430,000 | SH | SOLE | 430,000 | 0 | 0 | ||
INOZYME PHARMA INC | COM | 45790W108 | 3,519,616 | 3,867,710 | SH | SOLE | 3,867,710 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 10,680,600 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
ISHARES TR | RUSSELL 2000 ETF | 464287655 | 59,847,000 | 300,000 | SH | Put | SOLE | 300,000 | 0 | 0 | |
KARYOPHARM THERAPEUTICS INC | NOTE 3.000%10/1 | 48576UAA4 | 11,611,232 | 15,250,000 | PRN | SOLE | 15,250,000 | 0 | 0 | ||
KYMERA THERAPEUTICS INC | COM | 501575104 | 2,737,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
LEXEO THERAPEUTICS INC | COM | 52886X107 | 5,138,657 | 1,480,881 | SH | SOLE | 1,480,881 | 0 | 0 | ||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 26,498,400 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
MAZE THERAPEUTICS INC | COM | 578784100 | 2,752,500 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
MBX BIOSCIENCES INC | COM | 55287L101 | 1,291,500 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
MEIRAGTX HOLDINGS PLC | COM | G59665102 | 1,017,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 13,551,381 | 321,962 | SH | SOLE | 321,962 | 0 | 0 | ||
MINERALYS THERAPEUTICS INC | COM | 603170101 | 17,468,000 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
MINERALYS THERAPEUTICS INC | COM | 603170101 | 3,176,000 | 200,000 | SH | Put | SOLE | 200,000 | 0 | 0 | |
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 2,238,625 | 49,692 | SH | SOLE | 49,692 | 0 | 0 | ||
MONOPAR THERAPEUTICS INC | COM NEW | 61023L207 | 2,257,420 | 62,000 | SH | SOLE | 62,000 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 5,530,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | 6,652,750 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | 2,042,906 | 99,800 | SH | Call | SOLE | 99,800 | 0 | 0 | |
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | 1,535,250 | 75,000 | SH | Put | SOLE | 75,000 | 0 | 0 | |
NEWAMSTERDAM PHARMA COMPANY | *W EXP 99/99/999 | N62509117 | 2,746,212 | 241,957 | SH | SOLE | 241,957 | 0 | 0 | ||
NEXTCURE INC | COM | 65343E108 | 1,105,938 | 2,302,598 | SH | SOLE | 2,302,598 | 0 | 0 | ||
NKARTA INC | COM | 65487U108 | 1,472,000 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
NURIX THERAPEUTICS INC | COM | 67080M103 | 9,630,748 | 810,669 | SH | SOLE | 810,669 | 0 | 0 | ||
NUVALENT INC | COM | 670703107 | 32,623,200 | 460,000 | SH | SOLE | 460,000 | 0 | 0 | ||
OAKTREE ACQUISITION CORP III | UNIT 10/04/2029 | G6717R120 | 2,595,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 1,222,000 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
OMEROS CORP | COM | 682143102 | 81,855 | 9,958 | SH | SOLE | 9,958 | 0 | 0 | ||
OMEROS CORP | NOTE 5.250% 2/1 | 682143AG7 | 14,275,238 | 15,525,000 | PRN | SOLE | 15,525,000 | 0 | 0 | ||
ONKURE THERAPEUTICS INC | COM CL A | 68277Q105 | 1,694,884 | 394,159 | SH | SOLE | 394,159 | 0 | 0 | ||
ORUKA THERAPEUTICS INC | COM | 687604108 | 5,595,414 | 545,362 | SH | SOLE | 545,362 | 0 | 0 | ||
OVID THERAPEUTICS INC | COM | 690469101 | 208,198 | 667,516 | SH | SOLE | 667,516 | 0 | 0 | ||
PERCEPTIVE CAP SOLUTIONS COR | CL A ORD SHS | G70077105 | 3,619,000 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
PERSPECTIVE THERAPEUTICS INC | COM NEW | 46489V302 | 4,737,537 | 2,224,196 | SH | SOLE | 2,224,196 | 0 | 0 | ||
PROQR THRAPEUTICS N V | SHS EURO | N71542109 | 4,368,401 | 3,284,512 | SH | SOLE | 3,284,512 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 19,344,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 8,342,100 | 172,500 | SH | Call | SOLE | 172,500 | 0 | 0 | |
Q32 BIO INC | COM | 746964105 | 45,832 | 27,777 | SH | SOLE | 27,777 | 0 | 0 | ||
RADIOPHARM THERANOSTICS LTD | SPONSORED ADS | 75041J101 | 310,726 | 64,600 | SH | SOLE | 64,600 | 0 | 0 | ||
REPARE THERAPEUTICS INC | COM | 760273102 | 197,180 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
REZOLUTE INC | COM NEW | 76200L309 | 4,930,000 | 1,700,000 | SH | SOLE | 1,700,000 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | *W EXP 09/02/202 | 77313F114 | 3,525 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
ROIVANT SCIENCES LTD | SHS | G76279101 | 1,513,500 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
SOLENO THERAPEUTICS INC | COM | 834203309 | 3,572,500 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 16,781,700 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 223,756,000 | 400,000 | SH | Put | SOLE | 400,000 | 0 | 0 | |
SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | 40,550,000 | 500,000 | SH | Put | SOLE | 500,000 | 0 | 0 | |
SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | 7,771,875 | 481,678 | SH | SOLE | 481,678 | 0 | 0 | ||
SUTRO BIOPHARMA INC | COM | 869367102 | 489,721 | 752,722 | SH | SOLE | 752,722 | 0 | 0 | ||
TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 881624209 | 21,518,000 | 1,400,000 | SH | SOLE | 1,400,000 | 0 | 0 | ||
THIRD HARMONIC BIO INC | COM | 88427A107 | 1,283,900 | 370,000 | SH | SOLE | 370,000 | 0 | 0 | ||
TOURMALINE BIO INC | COM | 89157D105 | 1,521,000 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 19,174,400 | 1,070,000 | SH | SOLE | 1,070,000 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | NOTE 2.250% 3/0 | 89422GAA5 | 6,993,000 | 7,000,000 | PRN | SOLE | 7,000,000 | 0 | 0 | ||
TREVI THERAPEUTICS INC | COM | 89532M101 | 7,862,500 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
UNIQURE NV | SHS | N90064101 | 4,240,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 944,000 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
VERA THERAPEUTICS INC | CL A | 92337R101 | 8,530,535 | 355,143 | SH | SOLE | 355,143 | 0 | 0 | ||
VERA THERAPEUTICS INC | CL A | 92337R101 | 6,365,300 | 265,000 | SH | Call | SOLE | 265,000 | 0 | 0 | |
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 39,046,350 | 615,000 | SH | SOLE | 615,000 | 0 | 0 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | 603,750 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 5,257,200 | 390,000 | SH | SOLE | 390,000 | 0 | 0 | ||
WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 14,746,000 | 1,825,000 | SH | SOLE | 1,825,000 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 44,560,271 | 1,328,175 | SH | SOLE | 1,328,175 | 0 | 0 | ||
ZURA BIO LTD | CLASS A ORD SHS | G9TY5A101 | 288,102 | 223,335 | SH | SOLE | 223,335 | 0 | 0 |